Proteome and Secretome Profiling of the Melanoma-Induced Transition Toward Immune Incompetent Dendritic Cells Reveals Enhanced IDO1, Cathepsin, and Legumain Activity
Molecular & Cellular Proteomics · 2025
DOI: 10.1016/j.mcpro.2025.101048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2025. Verfasst von Anouk M D Becker und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Biochemistry & Pharmacology, Bio21 Molecular Science…. Hauptthemen laut MEDLINE: Dendritic Cells, Melanoma, Proteome, Cathepsins. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dendritic cells (DCs) are professional antigen-presenting cells endowed with the capacity to initiate strong antitumor immune responses. This function is critical for effective DC-based immunotherapies but is often hampered by tumor-derived immunosuppressive factors, as is observed for CD14+CD163+ tumor-induced DC3s (ti-DC3s). ti-DC3s are increased in cancer patients where they display an immunosuppressive phenotype, accompanied by weak antigen-specific CD8 T cell-activating capacities. While tumor-derived interleukin-6, macrophage colony-stimulating factor, and prostaglandin E2 have been identified as factors inducing the transition from DC2s to ti-DC3s, a comprehensive unbiased profiling of the resulting changes in secretome and proteome has not been reported. Here, we characterized by tandem LC-MS/MS the proteomic changes in conventional DCs during their transition into CD14+ ti-DC3s in vitro, using conditioned medium from the melanoma cell line BLM. This revealed 157 differentially expressed proteins, including upregulated indoleamine-2,3-dioxygenase 1 and legumain, which we confirmed to be functionally active. Next, we profiled the newly synthesized secretome in human DCs with THRONCAT metabolic labeling. We detected 17 differentially secreted proteins between DC2s and ti-DC3s, which included six cathepsins and tumor-associated transforming growth factor-β-induced protein. Cathepsin activity was validated in peripheral blood and tumor tissue of melanoma patients. We detected the highest cathepsin activity in ti-DC3s, surpassing DC2s and tumor-associated macrophages. Together, our findings represent the first characterization of the proteome and secretome of human melanoma-induced DC3s. This revealed several protein-driven protumor mechanisms active in ti-DC3s that potentially contribute to creating an immune environment favorable for tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Biochemistry & Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville,…
- Department of Synthetic Organic Chemistry, Chemical Biology Lab, Radboud University, Nijmegen, The Netherlands.
- Department of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands; Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
- Department of Biochemistry & Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Australia.
- Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Synthetic Organic Chemistry, Chemical Biology Lab, Radboud University, Nijmegen, The Netherlands; Institute for Chemical Immunology, Radboud University Medical Center, Nijmegen, The Netherlands; Chemical B…
Zitieren
APA
Becker, A. M. D., Ignacio, B. J., Dijkstra, J. J., Ziegler, A. R., Ramos-Tomillero, I., van Dalen, F. J., Edgington-Mitchell, L. E., Vermeulen, M., Bonger, K. M., de Vries, I. J. M., & Verdoes, M. (2025). Proteome and Secretome Profiling of the Melanoma-Induced Transition Toward Immune Incompetent Dendritic Cells Reveals Enhanced IDO1, Cathepsin, and Legumain Activity. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2025.101048
Vancouver
Becker AMD, Ignacio BJ, Dijkstra JJ, Ziegler AR, Ramos-Tomillero I, van Dalen FJ, et al. Proteome and Secretome Profiling of the Melanoma-Induced Transition Toward Immune Incompetent Dendritic Cells Reveals Enhanced IDO1, Cathepsin, and Legumain Activity. Molecular & Cellular Proteomics. 2025. doi:10.1016/j.mcpro.2025.101048
BibTeX
@article{Becker2025,
author = {Becker, Anouk M D and Ignacio, Bob J and Dijkstra, Jelmer J and Ziegler, Alexander R and Ramos-Tomillero, Iván and van Dalen, Floris J and Edgington-Mitchell, Laura E and Vermeulen, Michiel and Bonger, Kimberly M and de Vries, I Jolanda M and Verdoes, Martijn},
title = {Proteome and Secretome Profiling of the Melanoma-Induced Transition Toward Immune Incompetent Dendritic Cells Reveals Enhanced IDO1, Cathepsin, and Legumain Activity},
journal = {Molecular & Cellular Proteomics},
year = {2025},
doi = {10.1016/j.mcpro.2025.101048}
}
EUVIMED